OSTX
OS Therapies IncCompany with tickers: OSTX
CIK
1795091
CUSIP
68764Y207
Shares Outstanding
44,538,106
13F Activity (30d)
27 filings
25 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $7,351,723 | USD | 2026-03-31 | 10-Q | 2026-05-18 |
| Operating Income | $-10,167,938 | USD | 2026-03-31 | 10-Q | 2026-05-18 |
| Net Income | $-10,396,831 | USD | 2026-03-31 | 10-Q | 2026-05-18 |
| EPS (Basic) | $-0.27 | USD/shares | 2026-03-31 | 10-Q | 2026-05-18 |
| EPS (Diluted) | $-0.27 | USD/shares | 2026-03-31 | 10-Q | 2026-05-18 |